* Decided to participate in IPO – Inari Medical (NARI) *
On February 21, Inari Medical, a manufacturer of minimally invasive medical devices for the treatment of venous diseases, filed an IPO. The company’s products were used to treat more than 6,700 patients in 500 US hospitals (more than 90% of the treatment processes were in the 3rd quarter of 2018). In 2019, more than 4,562 procedures were performed.
* The company is growing in three-digit numbers and has achieved profitability. * In 2019, the growth rate was + 649%, the main growth drivers were an increase in the number of products sold and an increase in the average selling price. Gross margin is growing from 61% in 2018 to 88% in 2019.